Rhythm Pharmaceuticals (RYTM) Shares Issued (2017 - 2025)
Historic Shares Issued for Rhythm Pharmaceuticals (RYTM) over the last 9 years, with Q3 2025 value amounting to -$22.9 million.
- Rhythm Pharmaceuticals' Shares Issued fell 53737.34% to -$22.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.3 million, marking a year-over-year increase of 18734.79%. This contributed to the annual value of $39.1 million for FY2024, which is 1990.59% down from last year.
- According to the latest figures from Q3 2025, Rhythm Pharmaceuticals' Shares Issued is -$22.9 million, which was down 53737.34% from $34.0 million recorded in Q1 2025.
- Rhythm Pharmaceuticals' 5-year Shares Issued high stood at $161.7 million for Q1 2021, and its period low was -$22.9 million during Q3 2025.
- In the last 5 years, Rhythm Pharmaceuticals' Shares Issued had a median value of $5.8 million in 2024 and averaged $28.0 million.
- Its Shares Issued has fluctuated over the past 5 years, first soared by 28286000.0% in 2022, then plummeted by 53737.34% in 2025.
- Quarter analysis of 5 years shows Rhythm Pharmaceuticals' Shares Issued stood at -$5000.0 in 2021, then skyrocketed by 282860.0% to $14.1 million in 2022, then skyrocketed by 239.38% to $48.0 million in 2023, then crashed by 45.48% to $26.2 million in 2024, then crashed by 187.46% to -$22.9 million in 2025.
- Its last three reported values are -$22.9 million in Q3 2025, $34.0 million for Q1 2025, and $26.2 million during Q4 2024.